Belong.Life Secures $14M Series B Funding to Advance AI-Powered Big Data Platform for Cancer Patient Management

VCBeat (WeChat ID: vcbeat) has learned that on July 1, 2019, Belong.Life, the creator of the “Belong - Beating Cancer Together” mobile application, announced the completion of a $14 million Series B financing round. The round was led by IQVIA, with participation from The Group Ventures and other existing investors.

Belong was founded in 2015 by prominent entrepreneurs Eliran Malki, Irad Deutsch, and Ohad Rubin. The company operates the world’s largest social network for cancer patients and caregivers. The Belong global community provides access to a proprietary big data platform that enables users to connect anonymously, receive and share clinical information, and privately discuss issues related to their conditions. The company collaborates with world-class universities and publishes research findings alongside the American Society of Clinical Oncology (ASCO) and other organizations.

Belong.Life will use the funds from this financing round to advance and expand its cancer social network, launching a new Patient Engagement Platform (PEP), also known as the Patient Management Platform. This platform provides unique and innovative personalized solutions for cancer patients and their families, helping them manage and combat cancer more effectively. As a result, it is gaining increasing popularity among global healthcare providers, cancer patients, and life sciences companies. PEP is designed to enhance patient engagement, education levels, satisfaction, self-care coordination capabilities, and efficiency.

“We are honored to have the support and trust of IQVIA and other investors,” said Eliran Malki, Co-Founder and CEO of Belong.Life. “We are committed to building a more robust, hyper-personalized, and configurable patient engagement and research platform. Starting with ‘Together Against Cancer,’ we have rapidly grown into the world’s largest cancer social network and patient navigation app, partnering with leading, disruptive researchers and life sciences companies in the market. Now, in addition to expanding our global cancer coverage, Belong is bringing its technology and expertise to patients with other diseases to realize the company’s vision.”

“Our investment in Belong is aimed at accelerating and enhancing disruptive technologies in the healthcare industry,” said Tal Rosenberg, Senior Vice President of Global Technology Solutions at IQVIA. “With its unique patient engagement platform, featuring machine learning and artificial intelligence capabilities, Belong can leverage and optimize IQVIA’s solutions to improve the patient engagement experience.”

IQVIA is a global leader in advanced analytics, technology solutions, and contract research services for the life sciences industry. Founded in 2016 and headquartered in Connecticut, USA, the company is dedicated to providing clients with optimal problem-solving solutions, leading healthcare companies in technological innovation, maximizing opportunities, and advancing human health development. IQVIA was named one of the “World’s Most Admired Companies” in 2019.

The Group Ventures is a venture capital firm dedicated to investing in data-driven platform technology companies with B2B and two-sided network effect business models. The firm possesses extensive industry experience in the fields of data analytics, artificial intelligence, financial services, retail, healthcare, and manufacturing.

(Compiled by Cheng Tao)